Filing Flows › Comparisons › VYGR vs FDMT
Voyager Therapeutics vs 4D Molecular Therapeutics: VYGR and FDMT compared
Voyager Therapeutics is the larger company: $4.0M of revenue in its latest quarter (Q3 2026) against $3.8M for 4D Molecular Therapeutics (Q2 2026). 4D Molecular Therapeutics is growing faster (252× against -70% a year earlier).
Where the money goes: VYGR and FDMT
Voyager Therapeutics (VYGR) · Q3 2026
Voyager Therapeutics, Q3 2026: revenue $4.0M (-70% year over year), operating margin -658.2%, net loss $24.7M, operating cash flow −$19.7M. The chart follows the revenue to costs, profit and cash.
4D Molecular Therapeutics (FDMT) · Q2 2026
4D Molecular Therapeutics, Q2 2026: revenue $3.8M (252× year over year), net loss $72.9M, operating cash flow −$70.0M. The chart follows the revenue to costs, profit and cash.
| Voyager Therapeutics (VYGR) | 4D Molecular Therapeutics (FDMT) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q2 2026 |
| Revenue | $4.0M | $3.8M |
| Revenue growth, Y/Y | -70% | 252× |
| Operating margin | -658.2% | n/m |
| Net earnings | −$24.7M | −$72.9M |
| Net margin | -615.2% | — |
| Operating cash flow | −$19.7M | −$70.0M |
Questions
Which is bigger, Voyager Therapeutics or 4D Molecular Therapeutics?
Voyager Therapeutics is the larger company: $4.0M of revenue in its latest quarter (Q3 2026) against $3.8M for 4D Molecular Therapeutics (Q2 2026).
Is Voyager Therapeutics or 4D Molecular Therapeutics growing faster?
4D Molecular Therapeutics is growing faster (252× against -70% a year earlier).
More: Voyager Therapeutics earnings · how Voyager Therapeutics makes money · 4D Molecular Therapeutics earnings · how 4D Molecular Therapeutics makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 5, 2026; 10-Q filed Aug 13, 2026). Fiscal quarters can end on different dates. Not investment advice.